[(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate

C38H44O10 — CID 88870721

IUPAC[(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate
SMILESCC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(C(O)C4OC4(C)C)c2O1)O[C@]12C(=C[C@@H]4CC1C(C)(C)OC2(C/C=C(/C)OC=O)C4=O)C3=O
InChIInChI=1S/C38H44O10/c1-19(2)10-9-13-36(8)14-12-22-27(40)25-28(41)23-16-21-17-24-34(4,5)48-37(32(21)43,15-11-20(3)44-18-39)38(23,24)46-31(25)26(30(22)45-36)29(42)33-35(6,7)47-33/h10-12,14,16,18,21,24,29,33,40,42H,9,13,15,17H2,1-8H3/b20-11-/t21-,24?,29?,33?,36-,37?,38-/m1/s1
InChIKeyPVGHFWKFADSYSJ-VSBOKRGHSA-N
MW660.76 g/mol
LogP5.99
Rot. Bonds9

About [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate

[(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate (PubChem CID 88870721) has the molecular formula C38H44O10 and a molecular weight of 660.76 g/mol. Its IUPAC name is [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate.

Molecular Properties

Compound Name[(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate
PubChem CID88870721
Molecular FormulaC38H44O10
Molecular Weight660.76 g/mol
Exact Mass660.29
IUPAC Name[(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate
SMILESCC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(C(O)C4OC4(C)C)c2O1)O[C@]12C(=C[C@@H]4CC1C(C)(C)OC2(C/C=C(/C)OC=O)C4=O)C3=O
InChIInChI=1S/C38H44O10/c1-19(2)10-9-13-36(8)14-12-22-27(40)25-28(41)23-16-21-17-24-34(4,5)48-37(32(21)43,15-11-20(3)44-18-39)38(23,24)46-31(25)26(30(22)45-36)29(42)33-35(6,7)47-33/h10-12,14,16,18,21,24,29,33,40,42H,9,13,15,17H2,1-8H3/b20-11-/t21-,24?,29?,33?,36-,37?,38-/m1/s1
InChIKeyPVGHFWKFADSYSJ-VSBOKRGHSA-N
XLogP5.99
TPSA141.12 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds9
Heavy Atoms48
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500660.76
LogP ≤ 55.99
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate?
The IUPAC name of [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate (CID 88870721) is [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate.
What is the SMILES notation for [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate?
The canonical SMILES for [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate is CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(C(O)C4OC4(C)C)c2O1)O[C@]12C(=C[C@@H]4CC1C(C)(C)OC2(C/C=C(/C)OC=O)C4=O)C3=O.
What is the InChIKey of [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate?
The InChIKey is PVGHFWKFADSYSJ-VSBOKRGHSA-N. The full InChI is InChI=1S/C38H44O10/c1-19(2)10-9-13-36(8)14-12-22-27(40)25-28(41)23-16-21-17-24-34(4,5)48-37(32(21)43,15-11-20(3)44-18-39)38(23,24)46-31(25)26(30(22)45-36)29(42)33-35(6,7)47-33/h10-12,14,16,18,21,24,29,33,40,42H,9,13,15,17H2,1-8H3/b20-11-/t21-,24?,29?,33?,36-,37?,38-/m1/s1.
What are the key properties of [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate?
[(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate has a molecular weight of 660.76 g/mol, XLogP of 5.99, 9 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(Z)-4-[(2S,8R,17S)-5-[(3,3-dimethyloxiran-2-yl)-hydroxymethyl]-12-hydroxy-8,21,21-trimethyl-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]but-2-en-2-yl] formate is sourced from PubChem (CID 88870721), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).